Prevention and treatment of no-reflow phenomenon by targeting the coronary microcirculation

Area of Science:

• Cardiology
• Vascular Biology
• Interventional Cardiology

Background:

• Coronary no-reflow is a critical complication after percutaneous coronary intervention (PCI).
• It occurs despite successful revascularization, leading to inadequate myocardial perfusion.
• Microvascular alterations are the primary underlying mechanism.

Purpose of the Study:

• To provide an updated overview of the no-reflow phenomenon's pathomechanism.
• To review current prevention strategies focusing on coronary microcirculation.
• To highlight the importance of addressing microvascular dysfunction post-PCI.

Main Methods:

• Review of existing literature on coronary no-reflow.
• Analysis of pathomechanisms involving microvascular alterations.
• Evaluation of prevention strategies targeting vasoreactivity, platelet aggregation, inflammation, and embolization.

Main Results:

• No-reflow is linked to poor clinical outcomes, increasing morbidity and mortality.
• Effective prevention requires addressing microvascular factors like vasoreactivity, platelet aggregation, inflammation, and embolization.
• Current large randomized trials have not identified definitive treatments.

Conclusions:

• Understanding coronary microcirculation is crucial for managing no-reflow.
• Further research into microvascular targets may yield successful therapeutic strategies.
• Preventing no-reflow can significantly reduce adverse post-PCI clinical consequences.